FORTRESS BIOTECH, INC. received a stock award from AVENUE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/3/2024ACC: 0001104659-24-000853
10% Owner
Since Dec 2022
+2.10M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
2.10M acquired
Non-Derivative Transactions1
COMMON STOCK, PAR VALUE $0.0001
Direct
Shares
+2.10M
Price / share
—
Trade value
—
% of position
203.6%
1/2/2024
1.03M→3.13M
Total
Net shares
+2.10M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK, PAR VALUE $0.0001 Direct | 1/2/2024 | A · Award | +2.10M | — | — | 203.6% | 1.03M | 3.13M |
| Total | +2.10M | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported